The diabetic foot ulcers market size was valued at US$ 4,740.4 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.1% during 2022-2027. The diabetic foot ulcers market report provides an executive-level overview of the diabetic foot ulcers market worldwide today, with detailed forecasts of key indicators up to 2027.
This market intelligence report offers a thorough, forward-looking analysis of the diabetic foot ulcers market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.
This market intelligence report offers a thorough, forward-looking analysis of the diabetic foot ulcers market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.
Key Highlights
The diabetic foot ulcers market size was valued at US$ 4,740.4 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.1% during the forecast period (2022-2027). The market is driven by the rising prevalence of diabetes and resulting increase in incidence of diabetic foot ulcers and rise in geriatric population.Scope
- Overview of the diabetic foot ulcers market including industry trends, pipeline analysis, regulatory details, and product & company profile
- Diabetic foot ulcers market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the treatment, ulcers type, end-user, and geographic segments
- Diabetic foot ulcers market outlook: analysis as well as forecasts of revenue opportunities from the treatment segments
- Diabetic foot ulcers market outlook: analysis as well as forecasts of revenue opportunities from the ulcers type segment
- Diabetic foot ulcers market outlook: analysis as well as forecasts of revenue opportunities from the end-user segment
- The competitive landscape: an examination of the positioning of leading players in diabetic foot ulcers market
Reasons to Buy
- This market intelligence report offers a thorough, forward-looking analysis of the diabetic foot ulcers market and key opportunities in a concise format to help executives build proactive and profitable growth strategies
- Accompanying the publisher's Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in diabetic foot ulcers market
- The report also highlights key treatment, ulcer types, and end-user segments
- With different charts and tables, the report is designed for an executive-level audience, boasting presentation quality
- The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in diabetic foot ulcers market
Table of Contents
CHAPTER 01 Executive Summary
CHAPTER 02 Market Landscape
CHAPTER 03 Diabetic Foot Ulcers - Market Dynamics
CHAPTER 04 Global Diabetic Foot Ulcers Revenue Opportunity
CHAPTER 05 Diabetic Foot Ulcers Type Outlook
CHAPTER 06 Diabetic Foot Ulcers Treatment Outlook
CHAPTER 07 Diabetic Foot Ulcers End User Outlook
CHAPTER 08 Diabetic Foot Ulcers by Regional Outlook
CHAPTER 09 Diabetic Foot Ulcers - Competitive Landscape
CHAPTER 011 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Smith & Nephew Plc
- Coloplast A/S
- ConvaTec Group Plc
- Organogenesis Holdings Inc.
- Paracrine Inc.
- Alkem Laboratories Ltd.
- B. Braun Melsungen AG
- Molnlycke Health Care AB
- 3M Health Care
- Medline Industries Inc.